Intercostal catheter for analgesia post minimally invasive mitral valve surgery: A randomised, double blind study.
Not Applicable
- Conditions
- Analgesia post minimally invasive mitral valve surgeryI34.0Mitral (valve) insufficiency
- Registration Number
- DRKS00015650
- Lead Sponsor
- niversitätsklinikum Ulm, Sektion Kardioanästhesiologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 104
Inclusion Criteria
Minimally invasive mitral valve surgery.
Exclusion Criteria
Allergy against the medication put to use; ongoing use of antidepressants, antipsychotics, and analgetics; unability to use the VAS score.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Piritramid consumption during 8 hours postoperatively. The aim ist a score of 3 or below on the VAS; responsible for interviewing the Patient are the nursing staff.
- Secondary Outcome Measures
Name Time Method Ventilator time, Hospital time, Maximum VAS scores.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie intercostal catheter analgesia in minimally invasive mitral valve surgery?
How does intercostal catheter analgesia compare to standard-of-care pain management post minimally invasive mitral valve surgery?
Are there specific biomarkers that predict optimal patient response to intercostal catheter analgesia in I34.0 cases?
What adverse events are associated with intercostal catheter use for postoperative analgesia in cardiac surgery?
What combination analgesic approaches have been explored alongside intercostal catheters for minimally invasive mitral valve procedures?